These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 12665427

  • 21. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O.
    Biochem Pharmacol; 2005 Nov 25; 70(11):1673-84. PubMed ID: 16213467
    [Abstract] [Full Text] [Related]

  • 22. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
    Johnson G, Swart C, Moore SW.
    Biochem J; 2008 May 01; 411(3):507-14. PubMed ID: 18215127
    [Abstract] [Full Text] [Related]

  • 23. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T, Mallender WD, Thomas PJ, Rosenberry TL.
    Biochemistry; 1999 Jan 05; 38(1):122-33. PubMed ID: 9890890
    [Abstract] [Full Text] [Related]

  • 24. Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase.
    Liang D, Blouet JP, Borrega F, Bon S, Massoulié J.
    FEBS J; 2009 Jan 05; 276(1):94-108. PubMed ID: 19019080
    [Abstract] [Full Text] [Related]

  • 25. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
    Vitorović-Todorović MD, Juranić IO, Mandić LM, Drakulić BJ.
    Bioorg Med Chem; 2010 Feb 05; 18(3):1181-93. PubMed ID: 20061157
    [Abstract] [Full Text] [Related]

  • 26. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.
    Wong L, Radic Z, Brüggemann RJ, Hosea N, Berman HA, Taylor P.
    Biochemistry; 2000 May 16; 39(19):5750-7. PubMed ID: 10801325
    [Abstract] [Full Text] [Related]

  • 27. Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site.
    Antikainen NM, Hergenrother PJ, Harris MM, Corbett W, Martin SF.
    Biochemistry; 2003 Feb 18; 42(6):1603-10. PubMed ID: 12578373
    [Abstract] [Full Text] [Related]

  • 28. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Grigoryan HA, Hambardzumyan AA, Mkrtchyan MV, Topuzyan VO, Halebyan GP, Asatryan RS.
    Chem Biol Interact; 2008 Jan 10; 171(1):108-16. PubMed ID: 17980356
    [Abstract] [Full Text] [Related]

  • 29. Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis.
    Artursson E, Akfur C, Hörnberg A, Worek F, Ekström F.
    Toxicology; 2009 Nov 30; 265(3):108-14. PubMed ID: 19761810
    [Abstract] [Full Text] [Related]

  • 30. Allosteric control of acetylcholinesterase catalysis by fasciculin.
    Radić Z, Quinn DM, Vellom DC, Camp S, Taylor P.
    J Biol Chem; 1995 Sep 01; 270(35):20391-9. PubMed ID: 7657613
    [Abstract] [Full Text] [Related]

  • 31. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
    Boudinot E, Taysse L, Daulon S, Chatonnet A, Champagnat J, Foutz AS.
    Pharmacol Biochem Behav; 2005 Jan 01; 80(1):53-61. PubMed ID: 15652380
    [Abstract] [Full Text] [Related]

  • 32. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
    Bosak A, Gazić I, Vinković V, Kovarik Z.
    Chem Biol Interact; 2008 Sep 25; 175(1-3):192-5. PubMed ID: 18582854
    [Abstract] [Full Text] [Related]

  • 33. Functional requirements for the optimal catalytic configuration of the AChE active center.
    Shafferman A, Barak D, Kaplan D, Ordentlich A, Kronman C, Velan B.
    Chem Biol Interact; 2005 Dec 15; 157-158():123-31. PubMed ID: 16256968
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML, Bartolini M, Cavalli A, Andrisano V, Rosini M, Minarini A, Melchiorre C.
    J Med Chem; 2004 Nov 18; 47(24):5945-52. PubMed ID: 15537349
    [Abstract] [Full Text] [Related]

  • 35. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.
    Ekström F, Pang YP, Boman M, Artursson E, Akfur C, Börjegren S.
    Biochem Pharmacol; 2006 Aug 28; 72(5):597-607. PubMed ID: 16876764
    [Abstract] [Full Text] [Related]

  • 36. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
    Harel M, Sussman JL, Krejci E, Bon S, Chanal P, Massoulié J, Silman I.
    Proc Natl Acad Sci U S A; 1992 Nov 15; 89(22):10827-31. PubMed ID: 1438284
    [Abstract] [Full Text] [Related]

  • 37. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
    Loewenstein-Lichtenstein Y, Glick D, Gluzman N, Sternfeld M, Zakut H, Soreq H.
    Mol Pharmacol; 1996 Dec 15; 50(6):1423-31. PubMed ID: 8967962
    [Abstract] [Full Text] [Related]

  • 38. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
    Wang H, Vath GM, Gleason KJ, Hanna PE, Wagner CR.
    Biochemistry; 2004 Jun 29; 43(25):8234-46. PubMed ID: 15209520
    [Abstract] [Full Text] [Related]

  • 39. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A, Worek F, Szinicz L, Thiermann H.
    Toxicology; 2007 Apr 20; 233(1-3):166-72. PubMed ID: 16904809
    [Abstract] [Full Text] [Related]

  • 40. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
    Carletti E, Aurbek N, Gillon E, Loiodice M, Nicolet Y, Fontecilla-Camps JC, Masson P, Thiermann H, Nachon F, Worek F.
    Biochem J; 2009 Jun 12; 421(1):97-106. PubMed ID: 19368529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.